BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s): BVAXF

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.

CSE:BIOV - Post by User

BioVaxys Technology Corp.

<< Previous

Bullboard Posts

Next >>

Post by moneywagonon Oct 07, 2022 1:15pm

124 Views

Post# 35012681

BIOV~RAYMOND JAMES? ON BID @19 WAITING FOR PARTIAL FILL

Recent Trades - Last 10 of 203

TD & RBC super hungry alllll morning!

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
12:49:11	M	0.20	0.025	248	1 Anonymous	2 RBC
12:49:11	U	0.20	0.025	7,000	2 RBC	1 Anonymous	K
12:47:07	C	0.20	0.025	2,500	7 TD Sec	80 National Bank	K
12:37:29	C	0.19	0.015	500	89 Raymond James	80 National Bank	K
12:34:32	C	0.19	0.015	1,000	7 TD Sec	1 Anonymous	K
12:34:32	C	0.19	0.015	2,000	7 TD Sec	80 National Bank	K
12:34:32	C	0.19	0.015	325	7 TD Sec	80 National Bank	E
12:22:33	C	0.19	0.015	243	7 TD Sec	80 National Bank	E
12:22:33	O	0.19	0.015	10,000	1 Anonymous	1 Anonymous	K
12:22:33	C	0.19	0.015	7,000	7 TD Sec	1 Anonymous	K